Analysen von Florent Cespedes
06.01.25 | Sartorius vz. Underperform | Bernstein Research | |
06.01.25 | Sartorius vz. Underperform | Bernstein Research | |
20.12.24 | Novo Nordisk Underperform | Bernstein Research | |
04.12.24 | Novo Nordisk Underperform | Bernstein Research | |
21.10.24 | Novo Nordisk Underperform | Bernstein Research | |
07.08.24 | Novo Nordisk Underperform | Bernstein Research | |
22.06.18 | Novo Nordisk Sell | Société Générale Group S.A. (SG) | |
14.03.18 | Roche Sell | Société Générale Group S.A. (SG) | |
Werbung
|
|||
02.11.17 | Novo Nordisk Sell | Société Générale Group S.A. (SG) | |
23.03.17 | Novo Nordisk Sell | Société Générale Group S.A. (SG) | |
31.10.16 | Novo Nordisk Sell | Société Générale Group S.A. (SG) | |
28.04.16 | GSK Sell | Société Générale Group S.A. (SG) | |
29.10.15 | GSK Sell | Société Générale Group S.A. (SG) | |
10.09.15 | Novo Nordisk Sell | Société Générale Group S.A. (SG) | |
30.07.15 | GSK Sell | Société Générale Group S.A. (SG) | |
24.07.14 | GSK Underperform | BNP PARIBAS | |
27.05.14 | GSK Underperform | BNP PARIBAS | |
27.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
18.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
02.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
15.06.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
27.04.12 | AstraZeneca underperform | Exane-BNP Paribas SA |